Library / Laws / 119th Congress / Senate Bills / S. 1095
S. 1095
To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in Senate | 2025-03-24 | 6.3K | ⠃⠗⠋ |
| Reported in Senate | 2025-04-10 | 6.4K | ⠃⠗⠋ |